eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Stocks-KPTI-Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc KPTI

‎$‎7.67-1.23(-13.82%)(1D)
Delayed prices by NASDAQin USD
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Price Target
15.00
Based on analysts who covered KPTI
Invest in Karyopharm Therapeutics Inc
Today
Create an eToro account to buy KPTI stock on a secure, user-friendly, multi-asset trading platform.
Buy Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc KPTI

KPTI Stock Price Chart

‎-10.07‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered by
*Past performance is not an indication of future results
Asset stable trend

The Karyopharm Therapeutics Inc share price is stable this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Karyopharm Therapeutics Inc share price today is ‎$‎7.67, reflecting a ‎-13.82‎% change over the last 24 hours and ‎0‎% over the past week. The current market capitalization of KPTI is ‎$‎172.91M with an average volume in the last three months of 938907.53. The stock has a P/E ratio of -0.51 and a dividend yield of 0%. With the stock’s beta sitting at 1.01
KPTI Key Metrics
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎172.91M

Day’s Range
i
Shows the high and low prices of the day.
‎$‎7.5 - ‎$‎8.84

52W Range
i
Shows the high and low prices of the last year.
‎$‎5 - ‎$‎10.78

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
938907.53

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-0.51

Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎151.12M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎7.67

EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-15.09

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.01

How can I buy Karyopharm Therapeutics Inc stocks?

To purchase Karyopharm Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Karyopharm Therapeutics Inc (KPTI) page and place an order to buy Karyopharm Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
What Is Karyopharm Therapeutics Inc?
Karyopharm Therapeutics Inc is a US-based commercial-stage pharmaceutical business dedicated to researching and developing innovative first-in-class therapeutics. Its main goal is to meet significant unmet medical needs in cancer and other severe illnesses. The firm strives to provide novel therapies to people worldwide.

Operating within the healthcare sector, Karyopharm Therapeutics Inc specialises in developing oral small-molecule Selective Inhibitor of Nuclear Export (SINE) compounds. Its research is focused on developing novel therapeutic choices that will enhance outcomes for individuals suffering from life-threatening illnesses.

Keep track of the latest share price movements by adding KPTI to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.
CEO
Richard A. Paulson, MBA
Employees
228
Founded
2008
HQ
Newton, Massachusetts, US
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2026
Top Dividend Stocks for 2026
Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.
Read More
What Is Leverage and Margin?
What Is Leverage and Margin?
Leverage means using capital borrowed from a broker when opening a position. Sometimes traders may wish to apply leverage in order to obtain more exposure than the amount deposited, as part of their investment strategy.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.
Read More
Graph
Buy Karyopharm Therapeutics Inc
Invest in Karyopharm Therapeutics Inc
Today
Create an eToro account to buy KPTI stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of KPTI is ‎$‎7.67.
The average price target for Karyopharm Therapeutics Inc is ‎$‎15.00. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Karyopharm Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Karyopharm Therapeutics Inc is ‎$‎172.91M
Based on 3 analysts offering recommendations for KPTI in the last 3 months, the overall consensus is .
Scroll to top